LYEL
Price
$9.69
Change
+$0.26 (+2.76%)
Updated
Jul 3 closing price
Capitalization
143.49M
33 days until earnings call
SBMFF
Price
$0.68
Change
-$0.01 (-1.45%)
Updated
Jul 2 closing price
Capitalization
12.43B
Interact to see
Advertisement

LYEL vs SBMFF

Header iconLYEL vs SBMFF Comparison
Open Charts LYEL vs SBMFFBanner chart's image
Lyell Immunopharma
Price$9.69
Change+$0.26 (+2.76%)
Volume$35.84K
Capitalization143.49M
Sino Biopharmaceutical
Price$0.68
Change-$0.01 (-1.45%)
Volume$13.81K
Capitalization12.43B
LYEL vs SBMFF Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. SBMFF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and SBMFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (LYEL: $9.69 vs. SBMFF: $0.68)
Brand notoriety: LYEL and SBMFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 22% vs. SBMFF: 514%
Market capitalization -- LYEL: $143.49M vs. SBMFF: $12.43B
LYEL [@Biotechnology] is valued at $143.49M. SBMFF’s [@Biotechnology] market capitalization is $12.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileSBMFF’s FA Score has 2 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • SBMFF’s FA Score: 2 green, 3 red.
According to our system of comparison, SBMFF is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while SBMFF’s TA Score has 2 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 4 bearish.
  • SBMFF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than SBMFF.

Price Growth

LYEL (@Biotechnology) experienced а +6.25% price change this week, while SBMFF (@Biotechnology) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBMFF($12.4B) has a higher market cap than LYEL($143M). SBMFF YTD gains are higher at: 65.913 vs. LYEL (-24.297). SBMFF has higher annual earnings (EBITDA): 6.98B vs. LYEL (-204.02M). SBMFF has higher revenues than LYEL: SBMFF (26.2B) vs LYEL (65K).
LYELSBMFFLYEL / SBMFF
Capitalization143M12.4B1%
EBITDA-204.02M6.98B-3%
Gain YTD-24.29765.913-37%
P/E RatioN/A46.62-
Revenue65K26.2B0%
Total Cash301MN/A-
Total Debt48.9MN/A-
FUNDAMENTALS RATINGS
SBMFF: Fundamental Ratings
SBMFF
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELSBMFF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KAUG25.180.13
+0.50%
Innovator U.S. Small Cp Pwr Buf ETF -Aug
DOL59.780.09
+0.15%
WisdomTree International LargeCp Div ETF
XHYF37.85N/A
N/A
BondBloxx US Hg Yld Fncl & REIT Str ETF
SRHQ36.55N/A
N/A
SRH U.S. Quality GARP ETF
SPSB30.04-0.02
-0.07%
SPDR® Portfolio Short Term Corp Bd ETF

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+2.76%
VCYT - LYEL
46%
Loosely correlated
-0.25%
ZNTL - LYEL
42%
Loosely correlated
+1.61%
TYRA - LYEL
41%
Loosely correlated
-0.50%
CRBU - LYEL
40%
Loosely correlated
N/A
BEAM - LYEL
39%
Loosely correlated
+0.65%
More

SBMFF and

Correlation & Price change

A.I.dvisor tells us that SBMFF and PSTV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBMFF and PSTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBMFF
1D Price
Change %
SBMFF100%
N/A
PSTV - SBMFF
22%
Poorly correlated
-3.52%
BCDA - SBMFF
21%
Poorly correlated
+6.00%
INKT - SBMFF
21%
Poorly correlated
+0.86%
ALZN - SBMFF
20%
Poorly correlated
-2.00%
LYEL - SBMFF
20%
Poorly correlated
+2.76%
More